naltrexone has been researched along with thiophenes in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (46.15) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Coenen, A; Lasoń, W; Machelska, H; Przewłocka, B; Przewłocki, R; van Luijtelaar, G | 1 |
Lasoń, W; Machelska, H; Przewłocka, B | 1 |
Magyar, A; Medzihradszky, K; Rónai, AZ | 1 |
Grouhel, A; Wettstein, JG | 1 |
Angel, F; Chevalier, E; Dahl, SG; Friese, N; Junien, JL; Pascaud, X; Riviere, PJ | 1 |
Holtzman, SG; Powell, KR | 1 |
Bergman, J; Carey, GJ | 1 |
Gilpin, NW; Ji, D; Koob, GF; Richardson, HN; Rivier, CL | 1 |
Balog, T; Marotti, T; Martin-Kleiner, I | 1 |
Colontonio, MM; Cornett, EM; Gennuso, SA; Kaye, AD; Kaye, AJ; Latimer, DR; Patil, SS; Urman, RD; Vadivelu, N | 1 |
Banks, ML; Blough, BE; Faunce, KE; Grim, TW; Negus, SS; Obeng, S; Rice, KC; Schwienteck, KL; Zhang, Y | 1 |
Adekoya, P; Gulati, A; Hunter, C; Jones, MR; Kaye, AD; Kaye, AM; Kuppalli, S; Orhurhu, V; Seth, R; Urits, I | 1 |
Chang, HF; Chang, YC; Chao, YS; Chen, CT; Ke, YY; Law, PY; Lin, SY; Loh, HH; Ou, LC; Shih, C; Tao, PL; Tien, YW; Ueng, SH; Xi, JH; Yeh, SH | 1 |
2 review(s) available for naltrexone and thiophenes
Article | Year |
---|---|
New opioid receptor modulators and agonists.
Topics: Analgesics, Opioid; Animals; Diterpenes, Clerodane; Humans; Indoles; Naltrexone; Receptors, Opioid; Spiro Compounds; Thiophenes | 2018 |
Recent Advances in the Treatment of Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Drug Implants; Humans; Injections, Intramuscular; Methadone; Molecular Targeted Therapy; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Receptors, G-Protein-Coupled; Receptors, Opioid, mu; Secologanin Tryptamine Alkaloids; Thiophenes; Urea; Vaccines | 2021 |
11 other study(ies) available for naltrexone and thiophenes
Article | Year |
---|---|
Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Amino Acid Sequence; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electroencephalography; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Epilepsy, Absence; Injections, Intraventricular; Injections, Subcutaneous; Male; Molecular Sequence Data; Naltrexone; Pyrroles; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid, kappa; Receptors, Opioid, mu; Thiophenes | 1995 |
Kappa opioid receptor agonists inhibit the pilocarpine-induced seizures and toxicity in the mouse.
Topics: Analgesics; Animals; Benzeneacetamides; Brain; Injections, Intraperitoneal; Mice; Naltrexone; Pilocarpine; Pyrroles; Pyrrolidines; Receptors, Opioid, kappa; Seizures; Thiophenes | 1994 |
Kinetic parameters of antagonism by the delta opioid receptor selective peptide antagonist Boc-Tyr-Pro-Gly-Phe-Leu-Thr against selective and non-selective agonists in the mouse vas deferens.
Topics: Analgesics; Animals; Anticonvulsants; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enkephalin, Methionine; Enkephalins; In Vitro Techniques; Kinetics; Male; Mice; Mice, Inbred Strains; Morphine Derivatives; Naltrexone; Oligopeptides; Pyrroles; Receptors, Opioid, delta; Thiophenes; Vas Deferens | 1993 |
Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Formaldehyde; Male; Mice; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Pyrroles; Pyrrolidines; Receptors, Opioid, kappa; Receptors, Opioid, mu; Thiophenes | 1996 |
Reversal by kappa-agonists of peritoneal irritation-induced ileus and visceral pain in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Acetic Acid; Analgesics; Animals; Benzofurans; Benzomorphans; Cyclazocine; Fentanyl; Gastric Emptying; Intestinal Pseudo-Obstruction; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Peritoneum; Pyrroles; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Thiophenes | 1997 |
Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Behavior, Animal; Benzeneacetamides; Benzofurans; Benzomorphans; Conditioning, Operant; Dose-Response Relationship, Drug; Ethylketocyclazocine; Nalorphine; Naltrexone; Narcotic Antagonists; Pyrroles; Pyrrolidines; Receptors, Opioid, kappa; Reinforcement Schedule; Saimiri; Thiophenes | 1999 |
Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists.
Topics: Animals; Benzofurans; Discrimination Learning; Dose-Response Relationship, Drug; Male; Nalbuphine; Naltrexone; Narcotic Antagonists; Pyrroles; Pyrrolidines; Receptors, Opioid, kappa; Receptors, Opioid, mu; Saimiri; Thiophenes | 2001 |
Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats.
Topics: Alcohol Deterrents; Animals; Behavior, Addictive; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Ethanol; Male; Naltrexone; Pyrimidines; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Saccharin; Self Administration; Sweetening Agents; Thiophenes | 2008 |
Dynorphin inhibits NEP activity in R1.1 mouse thymoma cells.
Topics: Animals; Cell Line, Tumor; Dynorphins; Mice; Naltrexone; Narcotic Antagonists; Neprilysin; Receptors, Opioid, kappa; Thiophenes; Thymoma; Thymus Neoplasms | 2008 |
Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
Topics: Analgesics, Opioid; Animals; Discrimination Learning; Female; Fentanyl; Male; Morphine; Naltrexone; Narcotic Antagonists; Nociception; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Spiro Compounds; Thiophenes | 2019 |
Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone.
Topics: Analgesics, Opioid; Imidazoles; Naloxone; Naltrexone; Receptors, Opioid; Sulfonamides; Thiophenes | 2022 |